Search

Search Constraints

You searched for: Author/Creator Carbone, David P.

Search Results

1. An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients. Issue 9 (12th September 2022)

2. Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer. Issue 5 (June 2021)

4. Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunity. Issue 1 (7th May 2019)

5. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater. (December 2019)

6. Defining a standard set of patient-centred outcomes for lung cancer. Issue 3 (7th July 2016)

7. Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunity. Issue 1 (2nd April 2019)

10. First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes. (April 2023)